Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Oxytocin vs Expectant Management for Term PROM
NCT04307069Recruiting
- Sponsor
- Rambam Health Care Campus
- Start
- May 2020
- Primary completion
- May 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin in rupture of membranes (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Maternal infectious morbidity. Started May 2020; status: recruiting.
02
Drugs
oxytocin
03
Conditions
rupture of membranes
Beyond the preview
Go deeper on NCT04307069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04307069.